Rank | Gene Set | Z-score |
---|---|---|
1 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.42778316 |
2 | plasma membrane repair (GO:0001778) | 4.40515725 |
3 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.98427034 |
4 | barbed-end actin filament capping (GO:0051016) | 3.86328721 |
5 | cardiac myofibril assembly (GO:0055003) | 3.85143946 |
6 | basement membrane organization (GO:0071711) | 3.80353822 |
7 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.75175212 |
8 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.68317234 |
9 | pinocytosis (GO:0006907) | 3.65033758 |
10 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.54707113 |
11 | mannose metabolic process (GO:0006013) | 3.51394394 |
12 | lymph vessel development (GO:0001945) | 3.50969361 |
13 | low-density lipoprotein particle clearance (GO:0034383) | 3.28813127 |
14 | positive regulation of receptor recycling (GO:0001921) | 3.26147526 |
15 | myofibril assembly (GO:0030239) | 3.21895524 |
16 | positive regulation by symbiont of host defense response (GO:0052509) | 3.20685319 |
17 | modulation by symbiont of host defense response (GO:0052031) | 3.20685319 |
18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.20685319 |
19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.20685319 |
20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.20685319 |
21 | modulation by symbiont of host immune response (GO:0052553) | 3.20685319 |
22 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.17933131 |
23 | regulation of cholesterol storage (GO:0010885) | 3.15459307 |
24 | blood vessel maturation (GO:0001955) | 3.09357797 |
25 | wound healing, spreading of epidermal cells (GO:0035313) | 3.07956049 |
26 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.03209158 |
27 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.03075343 |
28 | morphogenesis of an endothelium (GO:0003159) | 3.03063932 |
29 | endothelial tube morphogenesis (GO:0061154) | 3.03063932 |
30 | sarcomere organization (GO:0045214) | 3.02607993 |
31 | protein localization to endosome (GO:0036010) | 3.02421176 |
32 | endodermal cell differentiation (GO:0035987) | 3.02096961 |
33 | heart trabecula formation (GO:0060347) | 3.01845083 |
34 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.97549268 |
35 | substrate-dependent cell migration (GO:0006929) | 2.96278872 |
36 | endothelial cell morphogenesis (GO:0001886) | 2.95928845 |
37 | negative regulation of focal adhesion assembly (GO:0051895) | 2.92186962 |
38 | negative regulation of cell junction assembly (GO:1901889) | 2.92186962 |
39 | negative regulation of adherens junction organization (GO:1903392) | 2.92186962 |
40 | growth hormone receptor signaling pathway (GO:0060396) | 2.89380010 |
41 | glycosphingolipid catabolic process (GO:0046479) | 2.89172148 |
42 | cell adhesion mediated by integrin (GO:0033627) | 2.87695678 |
43 | axon extension involved in axon guidance (GO:0048846) | 2.85779509 |
44 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.85779509 |
45 | endothelium development (GO:0003158) | 2.85085907 |
46 | response to peptidoglycan (GO:0032494) | 2.84964571 |
47 | cell migration involved in heart development (GO:0060973) | 2.80649852 |
48 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.79908726 |
49 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.77771981 |
50 | blood vessel endothelial cell migration (GO:0043534) | 2.77096378 |
51 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.75595165 |
52 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.75286693 |
53 | response to laminar fluid shear stress (GO:0034616) | 2.72586106 |
54 | surfactant homeostasis (GO:0043129) | 2.69546476 |
55 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.68982472 |
56 | regulation of early endosome to late endosome transport (GO:2000641) | 2.67971896 |
57 | cellular response to growth hormone stimulus (GO:0071378) | 2.67561941 |
58 | regulation of macrophage chemotaxis (GO:0010758) | 2.67373626 |
59 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.65161028 |
60 | apoptotic cell clearance (GO:0043277) | 2.64605558 |
61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.63726296 |
62 | negative regulation of endothelial cell migration (GO:0010596) | 2.63714435 |
63 | virion attachment to host cell (GO:0019062) | 2.63325415 |
64 | adhesion of symbiont to host cell (GO:0044650) | 2.63325415 |
65 | ovulation from ovarian follicle (GO:0001542) | 2.63200761 |
66 | * patterning of blood vessels (GO:0001569) | 2.61966164 |
67 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.61761197 |
68 | endothelial cell chemotaxis (GO:0035767) | 2.61603886 |
69 | lymphangiogenesis (GO:0001946) | 2.61325312 |
70 | negative regulation of granulocyte differentiation (GO:0030853) | 2.60068044 |
71 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.59705173 |
72 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.59276818 |
73 | adhesion of symbiont to host (GO:0044406) | 2.59065210 |
74 | positive regulation of vasculogenesis (GO:2001214) | 2.58597700 |
75 | stress fiber assembly (GO:0043149) | 2.58264952 |
76 | positive regulation of macrophage cytokine production (GO:0060907) | 2.58155849 |
77 | peptide catabolic process (GO:0043171) | 2.57702025 |
78 | adherens junction assembly (GO:0034333) | 2.57094667 |
79 | negative regulation of interleukin-12 production (GO:0032695) | 2.56942498 |
80 | response to thyroid hormone (GO:0097066) | 2.56740137 |
81 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.56435776 |
82 | amino sugar catabolic process (GO:0046348) | 2.56230368 |
83 | response to muramyl dipeptide (GO:0032495) | 2.55145891 |
84 | glomerular filtration (GO:0003094) | 2.55113930 |
85 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.54613189 |
86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.54526039 |
87 | positive regulation of odontogenesis (GO:0042482) | 2.53588710 |
88 | glycolipid catabolic process (GO:0019377) | 2.53539580 |
89 | response to fluid shear stress (GO:0034405) | 2.52112982 |
90 | * semaphorin-plexin signaling pathway (GO:0071526) | 2.51605383 |
91 | regulation of p38MAPK cascade (GO:1900744) | 2.51342665 |
92 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50801689 |
93 | keratan sulfate catabolic process (GO:0042340) | 2.50224376 |
94 | angiogenesis involved in wound healing (GO:0060055) | 2.50165835 |
95 | regulation of mononuclear cell migration (GO:0071675) | 2.49235397 |
96 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.46920690 |
97 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.45962723 |
98 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.45916064 |
99 | macrophage activation involved in immune response (GO:0002281) | 2.45792095 |
100 | cortical actin cytoskeleton organization (GO:0030866) | 2.45418825 |
101 | regulation of endothelial cell differentiation (GO:0045601) | 2.44998981 |
102 | cell communication by electrical coupling (GO:0010644) | 2.44770454 |
103 | regulation of leukocyte degranulation (GO:0043300) | 2.43335530 |
104 | positive regulation of lipid kinase activity (GO:0090218) | 2.42459925 |
105 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.42184264 |
106 | positive regulation of extracellular matrix organization (GO:1903055) | 2.42118081 |
107 | sprouting angiogenesis (GO:0002040) | 2.41876858 |
108 | negative regulation of platelet activation (GO:0010544) | 2.40402029 |
109 | positive regulation of p38MAPK cascade (GO:1900745) | 2.39451459 |
110 | negative regulation of vascular permeability (GO:0043116) | 2.38489771 |
111 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.37525935 |
112 | positive regulation of lipid storage (GO:0010884) | 2.37476047 |
113 | regulation of ARF GTPase activity (GO:0032312) | 2.36831165 |
114 | endocytic recycling (GO:0032456) | 2.36491873 |
115 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.36031508 |
116 | Notch signaling involved in heart development (GO:0061314) | 2.35997763 |
117 | negative regulation of heart growth (GO:0061117) | 2.34927089 |
118 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.34927089 |
119 | renal filtration (GO:0097205) | 2.34872819 |
120 | regulation of sequestering of triglyceride (GO:0010889) | 2.34610823 |
121 | coronary vasculature morphogenesis (GO:0060977) | 2.34534046 |
122 | regulation of extracellular matrix disassembly (GO:0010715) | 2.34133091 |
123 | fatty acid transmembrane transport (GO:1902001) | 2.34087003 |
124 | mRNA transcription (GO:0009299) | 2.33799004 |
125 | collagen metabolic process (GO:0032963) | 2.33077822 |
126 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.32886558 |
127 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.32707982 |
128 | cardiac muscle hypertrophy (GO:0003300) | 2.32100625 |
129 | oligosaccharide catabolic process (GO:0009313) | 2.32053050 |
130 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.31741164 |
131 | adenosine receptor signaling pathway (GO:0001973) | 2.31508613 |
132 | negative regulation of cell size (GO:0045792) | 2.31467127 |
133 | cell-substrate junction assembly (GO:0007044) | 2.31321033 |
134 | positive regulation of histone deacetylation (GO:0031065) | 2.31303628 |
135 | detection of molecule of bacterial origin (GO:0032490) | 2.30903895 |
136 | cell communication involved in cardiac conduction (GO:0086065) | 2.29980055 |
137 | focal adhesion assembly (GO:0048041) | 2.29089502 |
138 | cell-substrate adherens junction assembly (GO:0007045) | 2.29089502 |
139 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.29046511 |
140 | actomyosin structure organization (GO:0031032) | 2.28921905 |
141 | regulation of integrin activation (GO:0033623) | 2.28585710 |
142 | cardiac muscle contraction (GO:0060048) | 2.28515317 |
143 | collagen catabolic process (GO:0030574) | 2.28170358 |
144 | positive regulation of cholesterol efflux (GO:0010875) | 2.27498582 |
145 | fibril organization (GO:0097435) | 2.27009462 |
146 | venous blood vessel morphogenesis (GO:0048845) | 2.26916131 |
147 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.26305726 |
148 | phagocytosis (GO:0006909) | 2.24865890 |
149 | I-kappaB phosphorylation (GO:0007252) | 2.24276429 |
150 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.24201587 |
151 | hyaluronan catabolic process (GO:0030214) | 2.23242016 |
152 | establishment of endothelial barrier (GO:0061028) | 2.22676336 |
153 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.22258746 |
154 | vasculogenesis (GO:0001570) | 2.22181170 |
155 | regulation of vasculogenesis (GO:2001212) | 2.21244015 |
156 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.20269080 |
157 | regulation of sarcomere organization (GO:0060297) | 2.19738359 |
158 | positive regulation of glycogen metabolic process (GO:0070875) | 2.18954697 |
159 | cAMP biosynthetic process (GO:0006171) | 2.18875247 |
160 | muscle hypertrophy (GO:0014896) | 2.18759471 |
161 | striated muscle hypertrophy (GO:0014897) | 2.18641071 |
162 | regulation of actin filament-based movement (GO:1903115) | 2.18245681 |
163 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.17764576 |
164 | protein kinase C signaling (GO:0070528) | 2.17425393 |
165 | cardiac muscle cell development (GO:0055013) | 2.17128597 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.39841402 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.34683949 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.81663477 |
4 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.46430013 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.37052136 |
6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.31362921 |
7 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.27454804 |
8 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.20641093 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19662117 |
10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.09747161 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08412439 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.05548177 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03979848 |
14 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.00642223 |
15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.99538094 |
16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95763740 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.95175750 |
18 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.86249772 |
19 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84609928 |
20 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.79699183 |
21 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.79699183 |
22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.75381259 |
23 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74709544 |
24 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.74429075 |
25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73587006 |
26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.71344737 |
27 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71256833 |
28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69431932 |
29 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.67334128 |
30 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.67276885 |
31 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.63953167 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61524148 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60820061 |
34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.55550749 |
35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52950243 |
36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49432611 |
37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48890186 |
38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48392809 |
39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.47929195 |
40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.46131718 |
41 | GATA1_19941826_ChIP-Seq_K562_Human | 1.45961679 |
42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45810301 |
43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.45463684 |
44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44127535 |
45 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43669196 |
46 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42673285 |
47 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42465483 |
48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42303509 |
49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41602084 |
50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39990401 |
51 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39647648 |
52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38477519 |
53 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.37394600 |
54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35692687 |
55 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35367418 |
56 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35361704 |
57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35107144 |
58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34992808 |
59 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33039727 |
60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31896468 |
61 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31325597 |
62 | * MAF_26560356_Chip-Seq_TH1_Human | 1.31298753 |
63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30687993 |
64 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30305660 |
65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30113608 |
66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29750159 |
67 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27819351 |
68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25411742 |
69 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.25229498 |
70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23787915 |
71 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22951006 |
72 | MYC_22102868_ChIP-Seq_BL_Human | 1.20860512 |
73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.20517432 |
74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20238651 |
75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19143491 |
76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18774613 |
77 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.18017834 |
78 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16516584 |
79 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.16191065 |
80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14769323 |
81 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14337101 |
82 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13385692 |
83 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12353114 |
84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11902193 |
85 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10728349 |
86 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10673759 |
87 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09956474 |
88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08513381 |
89 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08432390 |
90 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.08205097 |
91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07146716 |
92 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05739171 |
93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05315049 |
94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05149115 |
95 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04587879 |
96 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04585427 |
97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04455023 |
98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04372779 |
99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04217678 |
100 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03509423 |
101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03154529 |
102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02955025 |
103 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01815000 |
104 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01404563 |
105 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01004537 |
106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00867294 |
107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98551226 |
108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98231983 |
109 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98098099 |
110 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98062749 |
111 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97831355 |
112 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96418172 |
113 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95790662 |
114 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95478793 |
115 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.95116302 |
116 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.94687549 |
117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94399364 |
118 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94260671 |
119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93520296 |
120 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93136707 |
121 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92761947 |
122 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92035174 |
123 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91184121 |
124 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89598465 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010368_abnormal_lymphatic_system | 5.36219659 |
2 | MP0004272_abnormal_basement_membrane | 3.83786996 |
3 | MP0001879_abnormal_lymphatic_vessel | 3.68954506 |
4 | MP0003705_abnormal_hypodermis_morpholog | 3.53836394 |
5 | MP0004084_abnormal_cardiac_muscle | 3.45554109 |
6 | MP0003303_peritoneal_inflammation | 3.33974610 |
7 | MP0005167_abnormal_blood-brain_barrier | 3.15304017 |
8 | MP0004510_myositis | 3.10683998 |
9 | MP0000751_myopathy | 2.78597917 |
10 | MP0003828_pulmonary_edema | 2.62287577 |
11 | MP0008438_abnormal_cutaneous_collagen | 2.62181492 |
12 | MP0002837_dystrophic_cardiac_calcinosis | 2.36688317 |
13 | MP0004130_abnormal_muscle_cell | 2.28760105 |
14 | MP0003279_aneurysm | 2.24597503 |
15 | MP0004036_abnormal_muscle_relaxation | 2.10624402 |
16 | MP0004215_abnormal_myocardial_fiber | 1.96501708 |
17 | MP0003566_abnormal_cell_adhesion | 1.96395710 |
18 | MP0003300_gastrointestinal_ulcer | 1.92083589 |
19 | MP0009278_abnormal_bone_marrow | 1.90768214 |
20 | MP0006054_spinal_hemorrhage | 1.83465292 |
21 | MP0010630_abnormal_cardiac_muscle | 1.82418480 |
22 | MP0005330_cardiomyopathy | 1.81970295 |
23 | MP0004087_abnormal_muscle_fiber | 1.81328521 |
24 | MP0008775_abnormal_heart_ventricle | 1.78930973 |
25 | MP0002877_abnormal_melanocyte_morpholog | 1.78243122 |
26 | MP0001544_abnormal_cardiovascular_syste | 1.76969723 |
27 | MP0005385_cardiovascular_system_phenoty | 1.76969723 |
28 | MP0005409_darkened_coat_color | 1.74720724 |
29 | MP0006138_congestive_heart_failure | 1.73828823 |
30 | MP0006082_CNS_inflammation | 1.69900331 |
31 | MP0002972_abnormal_cardiac_muscle | 1.69797274 |
32 | MP0005257_abnormal_intraocular_pressure | 1.63528295 |
33 | MP0000465_gastrointestinal_hemorrhage | 1.57389031 |
34 | MP0000569_abnormal_digit_pigmentation | 1.56029998 |
35 | MP0002933_joint_inflammation | 1.55593810 |
36 | MP0005623_abnormal_meninges_morphology | 1.55438799 |
37 | MP0005451_abnormal_body_composition | 1.49610325 |
38 | MP0000750_abnormal_muscle_regeneration | 1.47547602 |
39 | MP0001958_emphysema | 1.46105577 |
40 | * MP0000767_abnormal_smooth_muscle | 1.36370009 |
41 | MP0008260_abnormal_autophagy | 1.36359427 |
42 | MP0000343_altered_response_to | 1.36271858 |
43 | MP0000749_muscle_degeneration | 1.34784715 |
44 | MP0005023_abnormal_wound_healing | 1.32178402 |
45 | MP0005058_abnormal_lysosome_morphology | 1.24190867 |
46 | MP0005620_abnormal_muscle_contractility | 1.24062220 |
47 | MP0005076_abnormal_cell_differentiation | 1.23547296 |
48 | MP0002106_abnormal_muscle_physiology | 1.23065215 |
49 | MP0005275_abnormal_skin_tensile | 1.22787351 |
50 | MP0003091_abnormal_cell_migration | 1.22343608 |
51 | MP0003191_abnormal_cellular_cholesterol | 1.21814545 |
52 | MP0004185_abnormal_adipocyte_glucose | 1.21372201 |
53 | MP0004858_abnormal_nervous_system | 1.21151784 |
54 | MP0003646_muscle_fatigue | 1.20763023 |
55 | MP0004085_abnormal_heartbeat | 1.20504442 |
56 | MP0000858_altered_metastatic_potential | 1.19584225 |
57 | MP0009840_abnormal_foam_cell | 1.16977360 |
58 | MP0003172_abnormal_lysosome_physiology | 1.14839273 |
59 | MP0002148_abnormal_hypersensitivity_rea | 1.14465257 |
60 | MP0003329_amyloid_beta_deposits | 1.13285631 |
61 | MP0000733_abnormal_muscle_development | 1.12984066 |
62 | * MP0002128_abnormal_blood_circulation | 1.11511872 |
63 | MP0001835_abnormal_antigen_presentation | 1.10707784 |
64 | MP0002332_abnormal_exercise_endurance | 1.09662232 |
65 | MP0005390_skeleton_phenotype | 1.08302916 |
66 | MP0000249_abnormal_blood_vessel | 1.06257411 |
67 | MP0004484_altered_response_of | 1.05616585 |
68 | MP0002896_abnormal_bone_mineralization | 1.05205983 |
69 | MP0004145_abnormal_muscle_electrophysio | 1.04515332 |
70 | MP0003453_abnormal_keratinocyte_physiol | 1.02093248 |
71 | MP0002166_altered_tumor_susceptibility | 1.01934028 |
72 | * MP0001915_intracranial_hemorrhage | 1.01747808 |
73 | MP0003436_decreased_susceptibility_to | 1.01042137 |
74 | MP0005165_increased_susceptibility_to | 1.00236511 |
75 | MP0005164_abnormal_response_to | 0.99523701 |
76 | MP0002419_abnormal_innate_immunity | 0.98520177 |
77 | * MP0000266_abnormal_heart_morphology | 0.97249792 |
78 | MP0005666_abnormal_adipose_tissue | 0.97214385 |
79 | MP0001853_heart_inflammation | 0.97041080 |
80 | MP0005503_abnormal_tendon_morphology | 0.96835545 |
81 | MP0008961_abnormal_basal_metabolism | 0.96627941 |
82 | * MP0001614_abnormal_blood_vessel | 0.96382790 |
83 | * MP0002925_abnormal_cardiovascular_devel | 0.96236521 |
84 | MP0008004_abnormal_stomach_pH | 0.94388653 |
85 | MP0000759_abnormal_skeletal_muscle | 0.93420712 |
86 | MP0003075_altered_response_to | 0.91513551 |
87 | MP0000685_abnormal_immune_system | 0.90995375 |
88 | MP0003724_increased_susceptibility_to | 0.90335755 |
89 | MP0005369_muscle_phenotype | 0.90108627 |
90 | MP0001542_abnormal_bone_strength | 0.89710069 |
91 | MP0002998_abnormal_bone_remodeling | 0.89178876 |
92 | MP0004233_abnormal_muscle_weight | 0.88439362 |
93 | MP0002138_abnormal_hepatobiliary_system | 0.88331896 |
94 | MP0009785_altered_susceptibility_to | 0.88257165 |
95 | MP0003448_altered_tumor_morphology | 0.87608437 |
96 | MP0002295_abnormal_pulmonary_circulatio | 0.86664716 |
97 | MP0005375_adipose_tissue_phenotype | 0.86431756 |
98 | MP0004883_abnormal_blood_vessel | 0.86304445 |
99 | MP0005508_abnormal_skeleton_morphology | 0.85573687 |
100 | MP0003567_abnormal_fetal_cardiomyocyte | 0.84960428 |
101 | MP0009780_abnormal_chondrocyte_physiolo | 0.83800435 |
102 | MP0009764_decreased_sensitivity_to | 0.82607110 |
103 | MP0005387_immune_system_phenotype | 0.81972569 |
104 | MP0001790_abnormal_immune_system | 0.81972569 |
105 | MP0005464_abnormal_platelet_physiology | 0.81616831 |
106 | MP0003795_abnormal_bone_structure | 0.81416149 |
107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81220316 |
108 | MP0000604_amyloidosis | 0.81016942 |
109 | MP0002254_reproductive_system_inflammat | 0.80017282 |
110 | MP0002452_abnormal_antigen_presenting | 0.79660065 |
111 | MP0002405_respiratory_system_inflammati | 0.79381524 |
112 | MP0005166_decreased_susceptibility_to | 0.79266310 |
113 | MP0004947_skin_inflammation | 0.79099630 |
114 | MP0003045_fibrosis | 0.77853802 |
115 | MP0005397_hematopoietic_system_phenotyp | 0.77760645 |
116 | MP0001545_abnormal_hematopoietic_system | 0.77760645 |
117 | MP0000013_abnormal_adipose_tissue | 0.77566761 |
118 | MP0003137_abnormal_impulse_conducting | 0.77298746 |
119 | MP0003690_abnormal_glial_cell | 0.76733464 |
120 | MP0010155_abnormal_intestine_physiology | 0.76732155 |
121 | MP0004808_abnormal_hematopoietic_stem | 0.76059882 |
122 | MP0004782_abnormal_surfactant_physiolog | 0.74877492 |
123 | MP0002127_abnormal_cardiovascular_syste | 0.73812099 |
124 | MP0001849_ear_inflammation | 0.73645306 |
125 | MP0005670_abnormal_white_adipose | 0.73321938 |
126 | MP0005595_abnormal_vascular_smooth | 0.72763553 |
127 | MP0000003_abnormal_adipose_tissue | 0.72111107 |
128 | MP0001851_eye_inflammation | 0.71791430 |
129 | MP0001533_abnormal_skeleton_physiology | 0.71707017 |
130 | MP0010352_gastrointestinal_tract_polyps | 0.71395993 |
131 | MP0003634_abnormal_glial_cell | 0.71128442 |
132 | MP0002269_muscular_atrophy | 0.70179483 |
133 | MP0000747_muscle_weakness | 0.70003787 |
134 | MP0005388_respiratory_system_phenotype | 0.69964292 |
135 | MP0002133_abnormal_respiratory_system | 0.69964292 |
136 | MP0005000_abnormal_immune_tolerance | 0.68688654 |
137 | MP0005025_abnormal_response_to | 0.68173618 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.50157344 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.50157344 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.50157344 |
4 | Cerebral aneurysm (HP:0004944) | 4.32732797 |
5 | Sudden death (HP:0001699) | 3.93460741 |
6 | Protrusio acetabuli (HP:0003179) | 3.80928105 |
7 | Dysostosis multiplex (HP:0000943) | 3.74570637 |
8 | Increased connective tissue (HP:0009025) | 3.63191653 |
9 | Lymphangioma (HP:0100764) | 3.48557588 |
10 | Hematochezia (HP:0002573) | 3.38056404 |
11 | Systemic lupus erythematosus (HP:0002725) | 3.36407290 |
12 | Muscle fiber splitting (HP:0003555) | 3.29222689 |
13 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.18735320 |
14 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.18735320 |
15 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.18735320 |
16 | Ventricular tachycardia (HP:0004756) | 3.16755433 |
17 | Mucopolysacchariduria (HP:0008155) | 3.16631852 |
18 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.16631852 |
19 | Polycythemia (HP:0001901) | 3.08095957 |
20 | Hyporeflexia of lower limbs (HP:0002600) | 3.06108634 |
21 | Asymmetry of the thorax (HP:0001555) | 3.02831462 |
22 | Spontaneous hematomas (HP:0007420) | 3.02715394 |
23 | Difficulty running (HP:0009046) | 2.98271662 |
24 | Asymmetric septal hypertrophy (HP:0001670) | 2.92895742 |
25 | Atrial fibrillation (HP:0005110) | 2.89103890 |
26 | Broad metatarsal (HP:0001783) | 2.87614616 |
27 | Vertebral compression fractures (HP:0002953) | 2.86729239 |
28 | Vacuolated lymphocytes (HP:0001922) | 2.80488758 |
29 | Supraventricular arrhythmia (HP:0005115) | 2.77788753 |
30 | Primary atrial arrhythmia (HP:0001692) | 2.73054591 |
31 | Esophageal varix (HP:0002040) | 2.71454762 |
32 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.66964727 |
33 | Subaortic stenosis (HP:0001682) | 2.66964727 |
34 | Cervical subluxation (HP:0003308) | 2.66189907 |
35 | Atrioventricular block (HP:0001678) | 2.65470254 |
36 | Aneurysm (HP:0002617) | 2.63807220 |
37 | Nuclear cataract (HP:0100018) | 2.62927350 |
38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61421072 |
39 | Loss of speech (HP:0002371) | 2.55421103 |
40 | Lipoatrophy (HP:0100578) | 2.55309469 |
41 | Supraventricular tachycardia (HP:0004755) | 2.54471729 |
42 | Wrist flexion contracture (HP:0001239) | 2.53226425 |
43 | Vascular tortuosity (HP:0004948) | 2.50075267 |
44 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.49628217 |
45 | Neurofibrillary tangles (HP:0002185) | 2.48804504 |
46 | Abnormality of macrophages (HP:0004311) | 2.46352075 |
47 | Arterial tortuosity (HP:0005116) | 2.44774613 |
48 | Increased variability in muscle fiber diameter (HP:0003557) | 2.44516043 |
49 | Exercise-induced muscle cramps (HP:0003710) | 2.43862493 |
50 | Myotonia (HP:0002486) | 2.40277164 |
51 | Shallow orbits (HP:0000586) | 2.40007259 |
52 | Difficulty climbing stairs (HP:0003551) | 2.36963063 |
53 | Ankle contracture (HP:0006466) | 2.36055177 |
54 | Eczematoid dermatitis (HP:0000976) | 2.35087229 |
55 | Spondylolisthesis (HP:0003302) | 2.33404506 |
56 | Joint stiffness (HP:0001387) | 2.32632999 |
57 | Increased cerebral lipofuscin (HP:0011813) | 2.32346774 |
58 | Neonatal death (HP:0003811) | 2.31512807 |
59 | Skull defect (HP:0001362) | 2.28837736 |
60 | Subacute progressive viral hepatitis (HP:0006572) | 2.27041445 |
61 | Mitral valve prolapse (HP:0001634) | 2.22997262 |
62 | Heart block (HP:0012722) | 2.22418175 |
63 | Bundle branch block (HP:0011710) | 2.22116611 |
64 | Hemorrhage of the eye (HP:0011885) | 2.21886398 |
65 | J-shaped sella turcica (HP:0002680) | 2.21102659 |
66 | Porencephaly (HP:0002132) | 2.20414077 |
67 | Blue sclerae (HP:0000592) | 2.20119628 |
68 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.18992377 |
69 | Complement deficiency (HP:0004431) | 2.18563519 |
70 | Overgrowth (HP:0001548) | 2.18100148 |
71 | Myocardial infarction (HP:0001658) | 2.17549490 |
72 | Distal lower limb muscle weakness (HP:0009053) | 2.17204872 |
73 | Spinal rigidity (HP:0003306) | 2.16007439 |
74 | Hemiplegia (HP:0002301) | 2.15935468 |
75 | Abnormality of complement system (HP:0005339) | 2.15124788 |
76 | Amyloidosis (HP:0011034) | 2.14897876 |
77 | Glomerulonephritis (HP:0000099) | 2.14850351 |
78 | Abnormal atrioventricular conduction (HP:0005150) | 2.14037881 |
79 | Wormian bones (HP:0002645) | 2.13704808 |
80 | Right ventricular cardiomyopathy (HP:0011663) | 2.13245913 |
81 | Aortic aneurysm (HP:0004942) | 2.12383472 |
82 | EMG: myopathic abnormalities (HP:0003458) | 2.11293617 |
83 | Type 1 muscle fiber predominance (HP:0003803) | 2.10781515 |
84 | Visceral angiomatosis (HP:0100761) | 2.07576220 |
85 | Syncope (HP:0001279) | 2.07162437 |
86 | Premature rupture of membranes (HP:0001788) | 2.06804966 |
87 | Prolonged QT interval (HP:0001657) | 2.06254012 |
88 | Enlarged penis (HP:0000040) | 2.04181228 |
89 | Abnormality of the calf musculature (HP:0001430) | 2.03652707 |
90 | Cerebral inclusion bodies (HP:0100314) | 2.03507190 |
91 | Tetraparesis (HP:0002273) | 2.01958999 |
92 | Striae distensae (HP:0001065) | 2.01662861 |
93 | Axonal loss (HP:0003447) | 2.00466295 |
94 | Interstitial pulmonary disease (HP:0006530) | 2.00418468 |
95 | Hyperacusis (HP:0010780) | 2.00401180 |
96 | Bladder diverticulum (HP:0000015) | 2.00174469 |
97 | High pitched voice (HP:0001620) | 2.00133248 |
98 | Hemangiomatosis (HP:0007461) | 1.99650779 |
99 | Exercise-induced myalgia (HP:0003738) | 1.99529364 |
100 | Broad face (HP:0000283) | 1.99416623 |
101 | Purpura (HP:0000979) | 1.97756843 |
102 | Lower limb amyotrophy (HP:0007210) | 1.96645677 |
103 | Cerebral hemorrhage (HP:0001342) | 1.95228333 |
104 | Polygenic inheritance (HP:0010982) | 1.95189714 |
105 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.94903974 |
106 | Short 4th metacarpal (HP:0010044) | 1.94903974 |
107 | Apathy (HP:0000741) | 1.94430156 |
108 | Recurrent abscess formation (HP:0002722) | 1.93747658 |
109 | Genu recurvatum (HP:0002816) | 1.93630920 |
110 | Frequent falls (HP:0002359) | 1.92998686 |
111 | Peritonitis (HP:0002586) | 1.92693013 |
112 | Dilatation of the ascending aorta (HP:0005111) | 1.91620999 |
113 | Thoracic kyphosis (HP:0002942) | 1.90904485 |
114 | Disproportionate tall stature (HP:0001519) | 1.90468258 |
115 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90355310 |
116 | Thin bony cortex (HP:0002753) | 1.90306740 |
117 | Abnormality of the nasal mucosa (HP:0000433) | 1.88671217 |
118 | Diminished motivation (HP:0000745) | 1.85887023 |
119 | Pulmonary hypertension (HP:0002092) | 1.84765472 |
120 | Autoimmune thrombocytopenia (HP:0001973) | 1.83029723 |
121 | Aortic dissection (HP:0002647) | 1.82283267 |
122 | Long toe (HP:0010511) | 1.81727531 |
123 | Distal lower limb amyotrophy (HP:0008944) | 1.80959684 |
124 | Calf muscle hypertrophy (HP:0008981) | 1.80459290 |
125 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.80362981 |
126 | Osteolytic defects of the hand bones (HP:0009699) | 1.80362981 |
127 | Ventricular fibrillation (HP:0001663) | 1.80317509 |
128 | Obstructive sleep apnea (HP:0002870) | 1.79984046 |
129 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.78670546 |
130 | Dilated cardiomyopathy (HP:0001644) | 1.77969731 |
131 | Abnormality of the 4th metacarpal (HP:0010012) | 1.77437152 |
132 | Upper motor neuron abnormality (HP:0002127) | 1.76910373 |
133 | Fragile skin (HP:0001030) | 1.75557702 |
134 | Conjunctival telangiectasia (HP:0000524) | 1.75416374 |
135 | Ovoid vertebral bodies (HP:0003300) | 1.75321061 |
136 | Cellulitis (HP:0100658) | 1.75289569 |
137 | Upper limb amyotrophy (HP:0009129) | 1.74748033 |
138 | Distal upper limb amyotrophy (HP:0007149) | 1.74748033 |
139 | Nonimmune hydrops fetalis (HP:0001790) | 1.74277168 |
140 | Arterial thrombosis (HP:0004420) | 1.73274732 |
141 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.72987412 |
142 | Ventricular arrhythmia (HP:0004308) | 1.72572506 |
143 | Venous abnormality (HP:0002624) | 1.70201848 |
144 | Cortical dysplasia (HP:0002539) | 1.69261125 |
145 | Abnormality of the thoracic spine (HP:0100711) | 1.69108087 |
146 | Mitral stenosis (HP:0001718) | 1.68273629 |
147 | Stroke (HP:0001297) | 1.67925085 |
148 | Ectopia lentis (HP:0001083) | 1.67675851 |
149 | Recurrent bacterial skin infections (HP:0005406) | 1.67639520 |
150 | Joint laxity (HP:0001388) | 1.66940078 |
151 | Flexion contracture of toe (HP:0005830) | 1.66842962 |
152 | Joint contractures involving the joints of the feet (HP:0100492) | 1.66842962 |
153 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66750039 |
154 | Epistaxis (HP:0000421) | 1.66198441 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 6.51206006 |
2 | TRIB3 | 4.17683631 |
3 | PKN2 | 3.65924585 |
4 | KDR | 3.52935304 |
5 | TTN | 2.94727923 |
6 | RIPK1 | 2.70953017 |
7 | PRPF4B | 2.42937187 |
8 | ERN1 | 2.23257099 |
9 | IRAK3 | 2.18070845 |
10 | TGFBR2 | 2.14416005 |
11 | SCYL2 | 2.09494680 |
12 | PTK6 | 1.95079509 |
13 | SIK2 | 1.76846277 |
14 | DMPK | 1.75329958 |
15 | PTK2B | 1.68175141 |
16 | DDR2 | 1.63138802 |
17 | EPHB1 | 1.59011526 |
18 | MAP3K10 | 1.53762496 |
19 | CDC42BPA | 1.42704588 |
20 | PDGFRA | 1.39607464 |
21 | SMG1 | 1.37793226 |
22 | MAP4K1 | 1.36587358 |
23 | TBK1 | 1.28021328 |
24 | TYK2 | 1.27232176 |
25 | LMTK2 | 1.23199012 |
26 | NME2 | 1.19958046 |
27 | TESK1 | 1.19428564 |
28 | PHKG2 | 1.16801397 |
29 | PHKG1 | 1.16801397 |
30 | FGFR4 | 1.16521278 |
31 | CAMK1D | 1.14551004 |
32 | RIPK4 | 1.13323880 |
33 | DAPK2 | 1.11849486 |
34 | JAK1 | 1.10737959 |
35 | KSR2 | 1.09632609 |
36 | CAMK1G | 1.09211084 |
37 | EPHB2 | 1.08919831 |
38 | BMX | 1.08831212 |
39 | RET | 1.05488241 |
40 | SIK1 | 1.00276409 |
41 | TAOK2 | 0.98608398 |
42 | PRKD2 | 0.98129951 |
43 | PDGFRB | 0.98110384 |
44 | TGFBR1 | 0.97534157 |
45 | FGFR3 | 0.95969959 |
46 | CAMKK1 | 0.95678378 |
47 | MAP3K6 | 0.94065924 |
48 | MOS | 0.93633199 |
49 | MAP2K3 | 0.93387529 |
50 | MAP3K14 | 0.91152340 |
51 | PRKD3 | 0.88523423 |
52 | PRKCH | 0.88223589 |
53 | LRRK2 | 0.87547022 |
54 | PRKD1 | 0.82406132 |
55 | MAPK12 | 0.81967422 |
56 | MAPK7 | 0.81724049 |
57 | MAP3K7 | 0.81468234 |
58 | JAK3 | 0.78729719 |
59 | TYRO3 | 0.78217453 |
60 | PAK4 | 0.76960968 |
61 | FGR | 0.76832004 |
62 | KIT | 0.75002064 |
63 | JAK2 | 0.72935837 |
64 | CSK | 0.71950115 |
65 | FES | 0.70141170 |
66 | HCK | 0.69466627 |
67 | RPS6KL1 | 0.69053193 |
68 | RPS6KC1 | 0.69053193 |
69 | ABL2 | 0.68822194 |
70 | MYLK | 0.68741894 |
71 | TRPM7 | 0.68294643 |
72 | PRKG2 | 0.67938848 |
73 | ILK | 0.67093031 |
74 | PTK2 | 0.66427397 |
75 | MAP3K1 | 0.64595896 |
76 | PAK6 | 0.64491832 |
77 | TESK2 | 0.62171808 |
78 | RPS6KA2 | 0.61567735 |
79 | ZAP70 | 0.60878105 |
80 | MATK | 0.60594338 |
81 | LATS2 | 0.57913108 |
82 | PDPK1 | 0.57662382 |
83 | MTOR | 0.57395616 |
84 | ALK | 0.57103324 |
85 | ICK | 0.57063610 |
86 | MARK1 | 0.55288301 |
87 | MAPKAPK3 | 0.54254456 |
88 | NTRK1 | 0.54127552 |
89 | LATS1 | 0.53914041 |
90 | MAP3K13 | 0.53557437 |
91 | EGFR | 0.53276367 |
92 | BLK | 0.52840515 |
93 | STK24 | 0.51689398 |
94 | PRKAA2 | 0.51310575 |
95 | MAP3K11 | 0.50518722 |
96 | NEK9 | 0.50122343 |
97 | MAP3K9 | 0.50045183 |
98 | DAPK3 | 0.49943373 |
99 | SRC | 0.49210301 |
100 | TAOK1 | 0.49156781 |
101 | RPS6KA6 | 0.48222538 |
102 | ARAF | 0.47584639 |
103 | EEF2K | 0.46891205 |
104 | FLT3 | 0.46294714 |
105 | MARK2 | 0.45919696 |
106 | PDK1 | 0.45913096 |
107 | MARK3 | 0.45857418 |
108 | MAPK4 | 0.45580687 |
109 | CDK12 | 0.44548509 |
110 | HIPK2 | 0.43695509 |
111 | FYN | 0.43159374 |
112 | EPHA3 | 0.42958582 |
113 | SGK3 | 0.42523543 |
114 | CDK6 | 0.42001667 |
115 | BTK | 0.41431322 |
116 | PIM2 | 0.40834567 |
117 | PAK2 | 0.39716300 |
118 | NEK1 | 0.39472361 |
119 | LCK | 0.38776235 |
120 | GRK7 | 0.38748284 |
121 | CSF1R | 0.38288010 |
122 | IKBKE | 0.37996166 |
123 | CHUK | 0.37715891 |
124 | IRAK4 | 0.37226382 |
125 | ROCK1 | 0.35810680 |
126 | MAP3K3 | 0.33618461 |
127 | CAMK4 | 0.33152639 |
128 | ROCK2 | 0.33088440 |
129 | GSK3A | 0.33082305 |
130 | FER | 0.32703056 |
131 | SYK | 0.32010889 |
132 | PRKAA1 | 0.31762867 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.74889381 |
2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.92523283 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.83392371 |
4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.78519741 |
5 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75692501 |
6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.65189725 |
7 | Amoebiasis_Homo sapiens_hsa05146 | 1.60576784 |
8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.60044860 |
9 | Focal adhesion_Homo sapiens_hsa04510 | 1.59681495 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.55150262 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.52560368 |
12 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.49820281 |
13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.49489504 |
14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45901909 |
15 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.37045184 |
16 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34768762 |
17 | Bladder cancer_Homo sapiens_hsa05219 | 1.34571178 |
18 | Insulin resistance_Homo sapiens_hsa04931 | 1.32350756 |
19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28922058 |
20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27698388 |
21 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.26199353 |
22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25242789 |
23 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22915363 |
24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22657892 |
25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22368401 |
26 | Platelet activation_Homo sapiens_hsa04611 | 1.21637001 |
27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21602809 |
28 | Phagosome_Homo sapiens_hsa04145 | 1.20686503 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18587440 |
30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.17370910 |
31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17329711 |
32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16409592 |
33 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.16170812 |
34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14642395 |
35 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.14178429 |
36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.10375015 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06688031 |
38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.06403495 |
39 | Tuberculosis_Homo sapiens_hsa05152 | 1.06399446 |
40 | Adherens junction_Homo sapiens_hsa04520 | 1.05157563 |
41 | Pertussis_Homo sapiens_hsa05133 | 1.03688352 |
42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03115752 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97104606 |
44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97058693 |
45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96867161 |
46 | Renin secretion_Homo sapiens_hsa04924 | 0.94269127 |
47 | Salmonella infection_Homo sapiens_hsa05132 | 0.93857384 |
48 | Lysosome_Homo sapiens_hsa04142 | 0.93616243 |
49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.93382206 |
50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92518433 |
51 | Glioma_Homo sapiens_hsa05214 | 0.92454423 |
52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92135758 |
53 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.90376877 |
54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89111119 |
55 | Malaria_Homo sapiens_hsa05144 | 0.88381449 |
56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87546558 |
57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87251078 |
58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86867705 |
59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86336510 |
60 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.86173970 |
61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84588515 |
62 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84585370 |
63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83957014 |
64 | Lysine degradation_Homo sapiens_hsa00310 | 0.83148867 |
65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82172863 |
66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81943021 |
67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80762644 |
68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79950761 |
69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79641222 |
70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78551226 |
71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77180045 |
72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76760102 |
73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76664354 |
74 | Hepatitis C_Homo sapiens_hsa05160 | 0.76590813 |
75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74934457 |
76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74924988 |
77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74889995 |
78 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73909639 |
79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73096674 |
80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72370563 |
81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72315299 |
82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71833005 |
83 | Influenza A_Homo sapiens_hsa05164 | 0.71104546 |
84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68776496 |
85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68575089 |
86 | Endocytosis_Homo sapiens_hsa04144 | 0.68506052 |
87 | Apoptosis_Homo sapiens_hsa04210 | 0.68073945 |
88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67653395 |
89 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66710664 |
90 | Shigellosis_Homo sapiens_hsa05131 | 0.65919603 |
91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65684651 |
92 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64655328 |
93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64396756 |
94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64347052 |
95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64314100 |
96 | Axon guidance_Homo sapiens_hsa04360 | 0.63345886 |
97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63021303 |
98 | Measles_Homo sapiens_hsa05162 | 0.62759518 |
99 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62735746 |
100 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61364550 |
101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60529124 |
102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60494226 |
103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59788796 |
104 | Legionellosis_Homo sapiens_hsa05134 | 0.59741589 |
105 | Bile secretion_Homo sapiens_hsa04976 | 0.59588694 |
106 | Hepatitis B_Homo sapiens_hsa05161 | 0.59194429 |
107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58218908 |
108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57808826 |
109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57289457 |
110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56712435 |
111 | Gap junction_Homo sapiens_hsa04540 | 0.56436648 |
112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56221286 |
113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56169611 |
114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55395862 |
115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54894479 |
116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54744214 |
117 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54272798 |
118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54069308 |
119 | Prion diseases_Homo sapiens_hsa05020 | 0.53489828 |
120 | Asthma_Homo sapiens_hsa05310 | 0.53472636 |
121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53372979 |
122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51299864 |
123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51061508 |
124 | Allograft rejection_Homo sapiens_hsa05330 | 0.50685469 |
125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48900445 |
126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47838279 |
127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47768399 |